• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺激素治疗可抵消糖尿病器官中的细胞表型重塑。

Thyroid hormone treatment counteracts cellular phenotypical remodeling in diabetic organs.

作者信息

Lavecchia Angelo M, Mantzouratou Polyxeni, Cerullo Domenico, Locatelli Monica, Conti Sara, Tironi Matteo, Sangalli Fabio, Corna Daniela, Zoja Carlamaria, Remuzzi Giuseppe, Xinaris Christodoulos

机构信息

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Via Stezzano 87 -, 24126 Bergamo, Italy.

出版信息

iScience. 2023 Sep 7;26(10):107826. doi: 10.1016/j.isci.2023.107826. eCollection 2023 Oct 20.

DOI:10.1016/j.isci.2023.107826
PMID:37752946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10518716/
Abstract

Diabetes mellitus and alterations in thyroid hormone (TH) signaling are closely linked. Though the role of TH signaling in cell differentiation and growth is well known, it remains unclear whether its alterations contribute to the pathobiology of diabetic cells. Here, we aim to investigate whether the administration of exogenous T3 can counteract the cellular remodeling that occurs in diabetic cardiomyocytes, podocytes, and pancreatic beta cells. Treating diabetic rats with T3 prevents dedifferentiation, pathological growth, and ultrastructural alterations in podocytes and cardiomyocytes. , T3 reverses glucose-induced growth in human podocytes and cardiomyocytes, restores cardiomyocyte cytoarchitecture, and reverses pathological alterations in kidney and cardiac organoids. Finally, T3 treatment counteracts glucose-induced transdifferentiation, cell growth, and loss in pancreatic beta cells through TH receptor alpha1 activation. Our studies indicate that TH signaling activation substantially counteracts diabetes-induced pathological remodeling, and provide a potential therapeutic approach for the treatment of diabetes and its complications.

摘要

糖尿病与甲状腺激素(TH)信号传导的改变密切相关。尽管TH信号传导在细胞分化和生长中的作用已为人所知,但其改变是否促成糖尿病细胞的病理生物学仍不清楚。在这里,我们旨在研究外源性T3的给药是否可以抵消糖尿病心肌细胞、足细胞和胰腺β细胞中发生的细胞重塑。用T3治疗糖尿病大鼠可防止足细胞和心肌细胞的去分化、病理性生长和超微结构改变。此外,T3可逆转葡萄糖诱导的人足细胞和心肌细胞生长,恢复心肌细胞的细胞结构,并逆转肾脏和心脏类器官的病理改变。最后,T3治疗通过激活TH受体α1抵消葡萄糖诱导的胰腺β细胞转分化、细胞生长和丢失。我们的研究表明,TH信号传导激活可显著抵消糖尿病诱导的病理重塑,并为糖尿病及其并发症的治疗提供了一种潜在的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c99/10518716/6caa0490c414/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c99/10518716/0a80d3f6f852/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c99/10518716/af761947fb82/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c99/10518716/9f8d55825827/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c99/10518716/d5af8cda29aa/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c99/10518716/2b7c2e349e18/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c99/10518716/6caa0490c414/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c99/10518716/0a80d3f6f852/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c99/10518716/af761947fb82/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c99/10518716/9f8d55825827/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c99/10518716/d5af8cda29aa/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c99/10518716/2b7c2e349e18/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c99/10518716/6caa0490c414/gr5.jpg

相似文献

1
Thyroid hormone treatment counteracts cellular phenotypical remodeling in diabetic organs.甲状腺激素治疗可抵消糖尿病器官中的细胞表型重塑。
iScience. 2023 Sep 7;26(10):107826. doi: 10.1016/j.isci.2023.107826. eCollection 2023 Oct 20.
2
Alteration of thyroid hormone signaling triggers the diabetes-induced pathological growth, remodeling, and dedifferentiation of podocytes.甲状腺激素信号转导的改变触发了糖尿病诱导的足细胞的病理性生长、重塑和去分化。
JCI Insight. 2019 Sep 19;4(18):130249. doi: 10.1172/jci.insight.130249.
3
Thyroid hormone improves the mechanical performance of the post-infarcted diabetic myocardium: a response associated with up-regulation of Akt/mTOR and AMPK activation.甲状腺激素改善梗死后糖尿病心肌的力学性能:与 Akt/mTOR 上调和 AMPK 激活相关的反应。
Metabolism. 2013 Oct;62(10):1387-93. doi: 10.1016/j.metabol.2013.05.008. Epub 2013 Jun 15.
4
S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone.S100A8/MYD88/核因子κB:由甲状腺激素驱动的心肌细胞肥大所涉及的一条新途径。
J Mol Med (Berl). 2017 Jun;95(6):671-682. doi: 10.1007/s00109-017-1511-y. Epub 2017 Feb 4.
5
Thyroid hormone treatment decreases hepatic glucose production and renal reabsorption of glucose in alloxan-induced diabetic Wistar rats.甲状腺激素治疗可降低四氧嘧啶诱导的糖尿病Wistar大鼠的肝脏葡萄糖生成及肾脏对葡萄糖的重吸收。
Physiol Rep. 2016 Sep;4(18). doi: 10.14814/phy2.12961.
6
Thyroid hormone can favorably remodel the diabetic myocardium after acute myocardial infarction.甲状腺激素可使急性心肌梗死后的糖尿病心肌发生有利的重构。
Mol Cell Biochem. 2010 Dec;345(1-2):161-9. doi: 10.1007/s11010-010-0569-4. Epub 2010 Aug 22.
7
Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.血管紧张素1型受体通过Akt/GSK-3β/mTOR信号通路介导甲状腺激素诱导的心肌细胞肥大。
Basic Res Cardiol. 2009 Nov;104(6):653-67. doi: 10.1007/s00395-009-0043-1. Epub 2009 Jul 9.
8
O-GlcNAcylation of Histone Deacetylase 4 Protects the Diabetic Heart From Failure.O-连接的 N-乙酰葡萄糖胺修饰的组蛋白去乙酰化酶 4 保护糖尿病心脏免于衰竭。
Circulation. 2019 Aug 13;140(7):580-594. doi: 10.1161/CIRCULATIONAHA.117.031942. Epub 2019 Jun 14.
9
Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via Type 1 Angiotensin II receptor.心脏微小 RNA-133 在甲状腺激素介导的心脏肥厚中下调,部分是通过 1 型血管紧张素 II 受体。
Basic Res Cardiol. 2015 Sep;110(5):49. doi: 10.1007/s00395-015-0504-7. Epub 2015 Jul 23.
10
Thyroid Hormone-Regulated Cardiac microRNAs are Predicted to Suppress Pathological Hypertrophic Signaling.甲状腺激素调节的心脏微小RNA被预测可抑制病理性肥厚信号传导。
Front Endocrinol (Lausanne). 2014 Oct 20;5:171. doi: 10.3389/fendo.2014.00171. eCollection 2014.

引用本文的文献

1
Triiodothyronine protects infarcted myocardium by reducing apoptosis and preserving mitochondria.三碘甲状腺原氨酸通过减少细胞凋亡和保护线粒体来保护梗死心肌。
Basic Res Cardiol. 2025 Apr 15. doi: 10.1007/s00395-025-01106-z.
2
The role of advanced glycation end products between thyroid function and diabetic nephropathy and metabolic disorders.晚期糖基化终末产物在甲状腺功能、糖尿病肾病及代谢紊乱之间的作用。
Sci Rep. 2025 Feb 28;15(1):7202. doi: 10.1038/s41598-025-88806-7.

本文引用的文献

1
Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM).将胰高血糖素样肽-1 受体激动剂(GLP-1RAs)和钠-葡萄糖共转运蛋白 2 抑制剂(SGLT2is)联合用于 2 型糖尿病(T2DM)患者。
Cardiovasc Diabetol. 2023 Apr 1;22(1):79. doi: 10.1186/s12933-023-01798-4.
2
Cardiomyocyte Proliferation from Fetal- to Adult- and from Normal- to Hypertrophy and Failing Hearts.从胎儿期到成年期以及从正常心脏到肥厚性和衰竭性心脏的心肌细胞增殖
Biology (Basel). 2022 Jun 8;11(6):880. doi: 10.3390/biology11060880.
3
Association of Thyroid Hormone Treatment Intensity With Cardiovascular Mortality Among US Veterans.
甲状腺激素治疗强度与美国退伍军人心血管死亡率的关系。
JAMA Netw Open. 2022 May 2;5(5):e2211863. doi: 10.1001/jamanetworkopen.2022.11863.
4
Cell Hypertrophy: A "Biophysical Roadblock" to Reversing Kidney Injury.细胞肥大:逆转肾损伤的“生物物理障碍”。
Front Cell Dev Biol. 2022 Mar 3;10:854998. doi: 10.3389/fcell.2022.854998. eCollection 2022.
5
Effects of Acute Triiodothyronine Treatment in Patients with Anterior Myocardial Infarction Undergoing Primary Angioplasty: Evidence from a Pilot Randomized Clinical Trial (ThyRepair Study).急性三碘甲状腺原氨酸治疗对接受直接血管成形术的前壁心肌梗死患者的影响:一项初步随机临床试验(ThyRepair研究)的证据。
Thyroid. 2022 Jun;32(6):714-724. doi: 10.1089/thy.2021.0596. Epub 2022 May 5.
6
Thyroid Hormone Signalling in Human Evolution and Disease: A Novel Hypothesis.甲状腺激素信号在人类进化与疾病中的作用:一个新假说。
J Clin Med. 2021 Dec 23;11(1):43. doi: 10.3390/jcm11010043.
7
Thyroid Hormone Therapy and Incident Stroke.甲状腺激素治疗与卒中事件。
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3890-e3900. doi: 10.1210/clinem/dgab444.
8
A Brief Review of the Mechanisms of β-Cell Dedifferentiation in Type 2 Diabetes.2 型糖尿病中β细胞去分化机制的简要综述。
Nutrients. 2021 May 10;13(5):1593. doi: 10.3390/nu13051593.
9
The Plasticity of Pancreatic β-Cells.胰腺β细胞的可塑性
Metabolites. 2021 Apr 2;11(4):218. doi: 10.3390/metabo11040218.
10
Epigenetic Regulation of PDX-1 in Type 2 Diabetes Mellitus.2型糖尿病中PDX-1的表观遗传调控
Diabetes Metab Syndr Obes. 2021 Feb 2;14:431-442. doi: 10.2147/DMSO.S291932. eCollection 2021.